series-c-plus
Stage
3
Investors
About
Amylyx Pharmaceuticals develops novel therapies targeting diseases with high unmet medical needs, including treatments for post-bariatric hypoglycemia and amyotrophic lateral sclerosis.
Explore Amylyx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.